These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
501 related articles for article (PubMed ID: 14698956)
1. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells. Bisht KS; Bradbury CM; Zoberi I; Curry HA; Kaushal A; Roti Roti JL; Gius D Int J Radiat Biol; 2003 Nov; 79(11):879-88. PubMed ID: 14698956 [TBL] [Abstract][Full Text] [Related]
2. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687 [TBL] [Abstract][Full Text] [Related]
4. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor. Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor. Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107 [TBL] [Abstract][Full Text] [Related]
7. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth. Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells. Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848 [TBL] [Abstract][Full Text] [Related]
9. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
10. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955 [TBL] [Abstract][Full Text] [Related]
11. Radiation-induced adaptive response for protection against micronucleus formation and neoplastic transformation in C3H 10T1/2 mouse embryo cells. Azzam EI; Raaphorst GP; Mitchel RE Radiat Res; 1994 Apr; 138(1 Suppl):S28-31. PubMed ID: 8146320 [TBL] [Abstract][Full Text] [Related]
12. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model. Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613 [TBL] [Abstract][Full Text] [Related]
13. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308 [TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related]
17. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888 [TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1). Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts. Castaño E; Bartrons R; Gil J J Pharmacol Exp Ther; 2000 May; 293(2):509-13. PubMed ID: 10773022 [TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase 2 in human malignant melanoma. Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]